HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of atopic dermatitis with dupilumab in Taiwan: dynamic changes of IgE levels as a potential response biomarker.

AuthorsTzu Hung Huang, Yin-Chun Chen, Sheng-Yiao Lin, Szu-Hao Chiu, Ting-Ting Yang, Li-Wen Chiu, Yang-Yi Chen, Cheng-Che E Lan
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) Vol. 29 Issue 6 Pg. 658-659 (12 01 2019) ISSN: 1952-4013 [Electronic] France
PMID31903962 (Publication Type: Letter)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • Immunoglobulin E
  • dupilumab
Topics
  • Adult
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Biomarkers (blood)
  • Dermatitis, Atopic (blood, drug therapy)
  • Female
  • Humans
  • Immunoglobulin E (blood)
  • Male
  • Taiwan
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: